Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 08, 2017 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Issuance of US Patent for Topical Oral Film Technology

SAINT LAURENT, QUEBEC--(Marketwired - June 8, 2017) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) ("IntelGenx"), a leading oral drug delivery company primarily focused on the...
May 11, 2017 16:01 ET | Source: IntelGenx Technologies Corp.

IntelGenx Reports First Quarter 2017 Financial Results

SAINT LAURENT, QUEBEC--(Marketwired - May 11, 2017) - IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the...
May 04, 2017 16:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Report First Quarter 2017 Financial Results on May 11, 2017 - Conference Call to Follow

SAINT LAURENT, QUEBEC--(Marketwired - May 4, 2017) - IntelGenx Technologies Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), today announced that it will release its first quarter 2017 financial...
April 13, 2017 06:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx and RedHill Biopharma Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg

SAINT LAURENT, QUEBEC--(Marketwired - April 13, 2017) - The national marketing approval in Luxembourg completes the current approval process of...
April 05, 2017 16:14 ET | Source: IntelGenx Technologies Corp.

IntelGenx Files Preliminary Short Form Prospectus in Connection With a Proposed Offering of Convertible Unsecured Debentures

SAINT LAURENT, QUEBEC--(Marketwired - April 5, 2017) - IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Corporation" or "IntelGenx") is pleased to announce that it has...
April 04, 2017 10:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx Presents at the 13th International Conference on Alzheimer's and Parkinson's Diseases

SAINT LAURENT, QUEBEC--(Marketwired - April 4, 2017) - IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT)(the "Company" or "IntelGenx") announced today that Dr. Horst Zerbe, its...
April 03, 2017 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx and Tetra Bio-Pharma Announce the Signing of a Definitive Agreement for the Development and Commercialization of a Dronabinol XL Tablet

SAINT LAURENT, QUEBEC--(Marketwired - April 3, 2017) - IntelGenx Corp. ("IntelGenx") (TSX VENTURE:IGX)(OTCQX:IGXT) and Tetra Bio-Pharma Inc. ("Tetra") (CSE:TBP)(OTC PINK:GRPOF), today...
March 28, 2017 16:01 ET | Source: IntelGenx Technologies Corp.

IntelGenx Reports Fourth Quarter and Full-Year 2016 Financial Results

SAINT LAURENT, QUEBEC--(Marketwired - March 28, 2017) - IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the...
March 28, 2017 08:00 ET | Source: IntelGenx Technologies Corp.

Oral Film Exclusivity Granted to IntelGenx' VersaFilm(TM) for Tadalafil Erectile Dysfunction Dosing Patent

SAINT LAURENT, QUEBEC--(Marketwired - March 28, 2017) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today announced that Eli Lilly and Company granted...
March 21, 2017 16:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Report Fourth Quarter and Full Year 2016 Financial Results on March 28, 2017 - Conference Call to Follow

SAINT-LAURENT, QUEBEC--(Marketwired - March 21, 2017) - IntelGenx Technologies Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), today announced that it will release its fourth quarter and full year...